To further elucidate the immunoregulatory mechanism involved in the tolerance induction observed after MK626 treatment, the regulatory potential of CD8+ TEM has been assessed in the autoimmunity context of T1D. This evidence concerns the gene CD8A and type 1 diabetes mellitus.